In 2023, HSF Biotech passed the strict review of the State Intellectual Property Office and won the honorary title of "National Intellectual Property Demonstration Enterprise" with its strong R&D innovation and intellectual property management capabilities.
"National Intellectual Property Demonstration Enterprise" is the highest honor awarded by the state to enterprises for outstanding work in the creation, use, protection, and management of intellectual property. It is the highest evaluation of enterprise intellectual property management from a national perspective. HSF Biotech's award is the country's recognition of HSF's long-term achievements in intellectual property work and the construction of corporate intellectual property work.
As a high-tech biotechnology enterprise based on R&D and innovation, HSF Biotech has always adhered to the development strategy of building a company through technology and strengthening the company through technology. Under the leadership of CTO Professor Meng Yonghong, we continue to carry out technological innovation around core technologies and establish a multi-link and multi-level collaborative intellectual property standard management system such as patents, trademarks, copyrights, and trade secrets. Promote the construction of intellectual property demonstrations through multiple channels and measures, improve intellectual property management capabilities, fully implement intellectual property incentive policies, and promote the orderly development of intellectual property work. Currently participating in two national key R&D programs, HSF Biotech has undertaken 9 national and Shaanxi provincial science and technology projects, and has 63 invention patents in professional fields such as green manufacturing of oil/fruit functional ingredients and high-value utilization of oil/fruit by-products.
In the future, HSF Biotech will take this as a new starting point and actively expand into new fields. By strengthening the protection and management of intellectual property rights, we will promote the deep integration of intellectual property rights and industry, help create a more perfect, stronger and better core competitiveness of enterprises, and build a new development pattern for enterprises. In the context of the high-quality development of the health industry, we rely on leading biotechnology services to provide global partners with more comprehensive, effective and safer functional health solutions.